OTCMKTS:TRGM - Targeted Medical Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0060 0.00 (0.00 %)
(As of 05/23/2019 12:57 PM ET)
Previous Close$0.01
Today's Range$0.0060 - $0.0060
52-Week Range$0.0050 - $0.0688
Volume18,000 shs
Average Volume428 shs
Market Capitalization$176,820.00
P/E RatioN/A
Dividend YieldN/A
Beta0.62
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.

Receive TRGM News and Ratings via Email

Sign-up to receive the latest news and ratings for TRGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRGM
CUSIP876140104
Phone310-474-9809

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees30
Market Cap$176,820.00
Next Earnings DateN/A
OptionableNot Optionable

Targeted Medical Pharma (OTCMKTS:TRGM) Frequently Asked Questions

What is Targeted Medical Pharma's stock symbol?

Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."

Has Targeted Medical Pharma been receiving favorable news coverage?

News headlines about TRGM stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Targeted Medical Pharma earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned media coverage about the specialty pharmaceutical company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future.

Who are some of Targeted Medical Pharma's key competitors?

What other stocks do shareholders of Targeted Medical Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Targeted Medical Pharma investors own include Chesapeake Energy (CHK), Ceres (CERE), Chromadex (CDXC), Camtek (CAMT), Biocept (BIOC), ArQule (ARQL), Arena Pharmaceuticals (ARNA), ARI Network Services (ARIS), Amarin (AMRN) and Acer Therapeutics (ACER).

Who are Targeted Medical Pharma's key executives?

Targeted Medical Pharma's management team includes the folowing people:
  • Mr. William B. Horne, Chief Financial Officer (Age 51)
  • Mr. Douglas P. Gintz, Chief Marketing & Technology Officer (Age 52)
  • Mr. Kim Giffoni, Exec. VP of Foreign Sales & Director (Age 67)
  • Marcus Charuvastra, Interim CEO & Director

How do I buy shares of Targeted Medical Pharma?

Shares of TRGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Targeted Medical Pharma's stock price today?

One share of TRGM stock can currently be purchased for approximately $0.0060.

How big of a company is Targeted Medical Pharma?

Targeted Medical Pharma has a market capitalization of $176,820.00. Targeted Medical Pharma employs 30 workers across the globe.

What is Targeted Medical Pharma's official website?

The official website for Targeted Medical Pharma is http://www.targetedmedicalpharma.com/.

How can I contact Targeted Medical Pharma?

Targeted Medical Pharma's mailing address is 2980 BEVERLY GLEN CIRCLE SUITE 301, LOS ANGELES CA, 90077. The specialty pharmaceutical company can be reached via phone at 310-474-9809 or via email at [email protected]


MarketBeat Community Rating for Targeted Medical Pharma (OTCMKTS TRGM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about Targeted Medical Pharma and other stocks. Vote "Outperform" if you believe TRGM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRGM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel